Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
New York AG Pushes To Prohibit Crypto Investments With Retirement Funds
-
Crypto Analyst Says ‘BTC Miners Sell Roughly 100% of the Coins They Mine’
-
Market Trends At This Hour
-
First Republic Bank Shares Plunge; To Privately Place $125 Mln Of Shares
-
Former Goldman Sachs Exec on Ethereum: ‘This Is the Fastest Growing Economy on Earth’